Anti-tumor immunity induced by murine melanoma cells transduced with the Mycobacterium tuberculosis gene encoding the 38-kDa antigen

Gene Therapy

Volumn 5, Issue 2, 1998, Pages 247-252

  Sfondrini, L ^a   Morelli, D ^a   Menard S ^a   Maier, Jam ^c   Singh, M ^d   Melani, C ^b   Terrazzini, N ^b   Colombo, M P ^b   Colnaghi, M I ^a   Balsari, A ^b,e  

^a Division of Experimental Oncology E

^b NATIONAL CANCER INSTITUTE   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Cancer vaccine; Mouse melanoma; Mycobacterium tuberculosis

Indexed keywords

CANCER VACCINE; GAMMA INTERFERON; INTERLEUKIN 4; MEMBRANE PROTEIN; MYCOBACTERIUM ANTIGEN; NERVE GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENETIC TRANSDUCTION; HELPER CELL; IMMUNIZATION; IMMUNOGENICITY; LUNG METASTASIS; MELANOMA CELL; METASTASIS; MOLECULAR CLONING; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR GROWTH;

ANIMALIA; MURINAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 6844226195     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300575     Document Type: Article

References (26)

1. Pardoll DM. Cancer vaccines: a road map for the next decade. Curr Opin Immunol 1996, 8: 619-621.
2. Grange JM, Stanford JL, Rook GAW. Tuberculosis and cancer: parallels in host responses and therapeutic approaches? Lancet 1995; 345: 1350-1352.
3. Grange JM, Stanford JL. BCG vaccination and cancer. Tubercle 1990; 71: 61-64.
4. Musiani P et al. Cytokines, tumor-cell death and immunogenicity: a question of choice. Immunol Today 1997; 18: 32-36.
5. Bishop JM. Retroviruses and oncogenes II (Nobel lecture). Angewandte Chemie-Internatianal Edition 1990; 29: 716-724
6. Chirivi RGS et al. IL-la gene-transfected human melanoma cells increase tumor-cell adhesion to endothelial cells and their retention in the lung of nude mice. Int J Cancer 1996; 67: 856-863.
7. Kim TS, Russell SJ, Collins MKL, Cohen EP. Immunity to B16 melanoma in mice immunized with IL-2-secreting allogenic mouse fibroblasts expressing melanoma-associated antigens. Int J Cancer 1992; 51: 283-289.
8. Matzinger P. Tolerance, danger and the extended family. Annu Rev Immunol 1994; 12: 991-1045.
9. Singh M et al. The Mycobacterium tuberculosis 38-kDa antigen: overproduction in Esherichia coli, purification and characterization. Gene 1992; 117: 55-60.
10. Vordermeier HM et al. M. tuberculosis complex-specific T cell stimulation and DTH reactions induced with a peptide from the 38-kDa protein. Scand J Immunol 1992; 35: 711-718
11. Graf L, Kaplan P, Silagi S. Efficient DNA-mediated transfer of selectable genes and unselected sequences into differentiated and undifferentiated mouse melanoma clones. Somatic Cell Mol Genet 1984; 10: 139-151.
12. Poste G, Fidler IJ. The pathogenesis of cancer metastasis. Nature 1980; 283: 139-146.
13. Huygen K et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Med 1996; 2: 893-898.
14. Zhu X et al. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J Immunol 1997; 158: 5921-5926.
15. Lollini P et al. Enhancement of experimental metastatic ability by tumor necrosis factor-α alone or in combination with interferon-γ. Clin Exp Metastasis 1990; 8: 215-224.
16. Garrido F, Cabrera T, Lopez-Nevot MA, Ruiz-Cabello F. HLA class I antigens in human tumors. Adv Cancer Res 1995; 67: 155-195
17. Sredni B et al. Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101. J Natl Cancer Inst 1996; 88: 1276-1284
18. Lukacs KV, Lowrie DB, Stokes RW, Colston MJ. Tumor cells transfected with a bacterial heat-shock gene lose tumorigenicity and induce protection against tumors. J Exp Med 1993, 178: 343-348.
19. Schweighoffer T. Tumor cells expressing a recall antigen are powerful cancer vaccines. Eur J Immunol 1996; 26: 2559-2564
20. Hartl FU. Molecular chaperones in cellular protein folding. Nature 1996; 381: 571-580.
21. Blachere NE, Srivastava PK. Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors. Semin Cancer Biol 1995; 6: 349-355.
22. Young DB, Garbe TR. Lipoprotein antigens of Mycobacteriun tuberculosis. Res Microbiol 1991; 142: 55-65.
23. Colombo MP et al. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J Exp Med 1991; 173: 889-897.
24. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line Virology 1988; 167: 400-406.
25. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988; 62: 1120-1124.
26. Landowski TH, Dratz EA, Starkey JR. Studies of the structure of the metastasis-associated 67 kDa lammin binding protein: fatty acid acylation and evidence supporting dimerization of the 32 kDa gene product to form the mature protein. Biochemistry 1995; 34: 11276-11287.